Vicarious Surgical Inc. (NYSE:RBOT) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET

Company Participants

Kaitlyn Brosco - Director, Investor Relations

Adam Sachs - Chief Executive Officer

Bill Kelly - Chief Financial Officer

Conference Call Participants

Matt Miksic - Barclays

Operator

Good afternoon and welcome to Vicarious Surgical's Second Quarter 2022 Earnings Conference Call. My name is Brica, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes.

I would now like to turn the conference over to Kaitlyn Brosco, Director of Investor Relations of Vicarious Surgical for some introductory remarks. So, Kaitlyn, you may begin.

Kaitlyn Brosco

Thanks Brica and thank you you all for participating in today's call. Earlier today, Vicarious Surgical released preliminary unaudited financial results for the three months ended June 30th, 2022. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.

Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements. All forward-looking statements, including, without limitation, those relating to our operating trends and future financial performance, expense management, market opportunity, and commercialization are based upon our current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements.

Accordingly, you should not place undue reliance on these statements. For a list and descriptions of the risks and uncertainties associated with our business, please refer to the Risk Factors set forth in our annual report on Form 10-K filed for the year ended December 31st, 2021 filed with the Securities and Exchange Commission on March 31st, 2022 and our reports we may file with the SEC from time-to-time.

This conference call contains time-sensitive information and is accurate only as of the live broadcast today, August 8th, 2022. Vicarious Surgical disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise.